Combining PARP+ PD-L1 inhibitors Combining PARP+ PD-L1 inhibitors

POSTED: January 29, 2019

Combining PARP+ PD-L1 inhibitors


Dr. Fatima Karzai is the Director of the Prostate Cancer Clinic for the Genitourinary Branch at the National Cancer Institute. She’s keenly interested in developing...

Combining Keytruda (pembrolizumab) and Xtandi (enzalutamide) For Prostate Cancer

POSTED: January 22, 2019

Combining Keytruda (pembrolizumab) and Xtandi (enzalutamide) For Prostate Cancer


Dr. Julie Graff on combining Keytruda (pembrolizumab) with Xtandi (enzalutamide) for prostate cancer … Continue reading →

POSTED: January 18, 2019

Prostate Cancer Vaccine Clinical Trials


Dr. James Gulley is the Head of the Immunotherapy Section and the Director of the Medical Oncology...

Who Is Dr. James Gulley?

POSTED: January 16, 2019

Who Is Dr. James Gulley?


Dr. James Gulley is the Head of the Immunotherapy Section and the Director of the Medical Oncology...

Immunotherapy For Prostate Cancer

POSTED: January 10, 2019

Immunotherapy For Prostate Cancer


In January, we’re talking about immunotherapy for prostate cancer. Dr. Charles Myers introduced the issue for us....

Search

Mailing List

Popular Posts

Stay Connected